NIKE, Inc.
NKE remains a real turnaround story, but at $39.60 the stock already reflects much of the margin repair while management is still guiding revenue down low to mid-single digits and half the portfolio remains under pressure.
Nike is no longer the broken story it was a year ago, but it is not yet the recovered story the valuation still implies. The hard evidence is straightforward: FY2026 revenue fell to $46.4B, down 6.9%, EPS dropped 19.7% to $2.10, and the latest quarter's reported $0.72 EPS was flattered by a $986M one-time tariff recovery. Ex-benefit EPS was only $0.20. That makes the apparent earnings momentum look much better than the underlying business actually is.
The central debate is whether the margin recovery can carry the stock before demand returns. There is progress here. FY2026 operating margin improved to 10.4% from 8.0%, Q4 EBITDA margin reached 12.9%, the company took more than $2B out of classic footwear franchises to clean up the portfolio, and North America wholesale grew 10%. Those are real wins. But they sit beside management's own warning that "We are not expecting the environment to improve meaningfully over the next 6 months." Even more important, Elliott Hill said Sportswear and Jordan Streetwear will remain negative this fiscal year, and together they are approximately half of revenue. That is not a minor pocket of weakness. It is the core of the revenue base.
The market also has to deal with an uneven moat. Nike still owns one of the few truly global athletic brands, and that matters. But the competitive advantage has shifted away from broad lifestyle dominance toward narrower strength in performance categories. Q4 performance sports grew mid-single digits, while China fell 17% and lifestyle remains under pressure. That leaves the company with a durable franchise, but a less powerful growth engine than investors were accustomed to three to five years ago.
At this price, the risk is not permanent impairment, it is dead money or another leg down if the next few quarters confirm that growth is still missing. The stock is already down 48.8% from the 52-week high and 23.9% below the 200-day average, so the easy bearish money has likely been made. That keeps conviction at Medium, not High. But absent a cleaner proof that new product launches in 2H FY27 can offset weakness in half the portfolio and stabilize China, the setup still favors a SELL over patience.
New footwear launches in 2H FY27 work, Sportswear and Jordan inflect faster than planned, and a cleaner marketplace allows investors to lean toward the $51.24 to $51.49 P/S and DCF methods.
Margin improvement offsets soft demand, but with Q1 revenue down low to mid-single digits and no near-term macro lift, shares hover around the engine target.
Revenue declines persist into FY27, China stays weak after the 17% Q4 drop, and the market values NKE closer to the engine's $30.79 P/E-based method.
Quant call (HOLD) diverges from analyst consensus (Buy: 7 buy / 13 hold / 2 sell) — resolve explicitly.
We suffer more often in imagination than in reality.
Forward earnings still look fragile relative to the headline valuation. The stock trades at 18.26x trailing earnings, but the more relevant read is that management is guiding another period of low to mid-single digit revenue declines while approximately half of revenue in Sportswear and Jordan Streetwear stays negative, which limits near-term EPS compounding. The moat remains real in brand, distribution, and athlete endorsement, but it is narrower than it was 3 to 5 years ago because challenger brands have taken share through faster product cycles and more focused innovation. AI is more likely to be an efficiency tool for inventory, allocation, and product design than a major growth unlock for Nike, so it helps margins more than demand, and that is not enough for a positive rating while category growth and China remain weak.
- FY2026 revenue declined to $46.4B, down 6.9% YoY, showing the reset is still shrinking the business even as margins recover.
- Reported Q4 EPS of $0.72 included a $986M one-time tariff recovery, with EPS ex-benefit only $0.20, a much weaker read on normalized earnings power.
- Management now guides Q1 FY27 revenue down low to mid-single digits, while Sportswear and Jordan Streetwear, approximately half of revenue, are expected to stay negative this fiscal year.
- Operating margin improved to 10.4% in FY2026 from 8.0% in the prior year, showing the supply-chain and portfolio reset is producing real cost leverage.
- Q4 EBITDA reached $1.42B at a 12.9% margin, up 690 bps versus Q1 FY26 and 770 bps versus prior-year Q4, indicating better operating discipline.
- Performance sports grew mid-single digits in Q4, and North America wholesale grew 10%, with Foot Locker turning positive for the first time in 4 years.
- Classic footwear franchises were reduced by more than $2B in FY26, which should clean the channel and support a healthier product mix into 2H FY27.
- Normalized profitability is weaker than the headline quarter suggests, because the $0.72 Q4 EPS falls to $0.20 excluding the $986M tariff benefit.
- Greater China revenue fell 17% in Q4, and management said near-term trends should remain in line with recent performance, leaving a major geography without a visible rebound.
- Management explicitly said, "We are not expecting the environment to improve meaningfully over the next 6 months," while guiding only slightly positive Q1 gross margin and flat SG&A dollars.
- Valuation is not washed out enough for a shrinking earnings base: NKE trades at 18.26x earnings, essentially in line with the 18.1x peer average, despite lower growth and wide peer dispersion of 3.4x.
| Metric | Value | Context |
|---|---|---|
| Current price | $39.60 | Engine base target implies only 0.2% upside |
| Price target | $39.67 | Ground-truth target, Medium confidence, basis earnings_growth_blend |
| FY2026 revenue | $46.4B | -6.9% YoY, still shrinking despite reset actions |
| FY2026 EPS | $2.10 | -19.7% YoY, weak earnings base for a turnaround |
| Operating margin | 10.4% | Up from 8.0% in prior FY, clear cost and mix recovery |
| Valuation | P/E 18.26x, P/S 1.23x | P/E roughly in line with peer avg 18.1x, P/S below peer avg 1.5x |
| Leverage | Debt/EBITDA 2.79x | Manageable, but not balance-sheet-clean for a consumer reset story |
| Free cash flow | $1.5B | Low versus historic Nike standards, with capex only $0.1B |
| Q4 FY26 EBITDA | $1.42B | 12.9% margin, up 690 bps vs Q1 FY26 |
| Q1 FY27 guidance | Revenue down low to mid-single digits | Gross margin only slightly positive, SG&A dollars flat |
| 52-week position | -48.8% vs high | Stock near lows, now $38.17-$77.37 52-week range |
| Short interest | 5.85% | 68.8M shares short, 2.8 days-to-cover |
The biggest risk to the bearish view is that margin repair outruns revenue pressure, because FY2026 operating margin already recovered to 10.4% from 8.0% and Q4 EBITDA margin hit 12.9%.
Fiscal Q1 2027 earnings on September 29, 2026, especially whether revenue remains down low to mid-single digits and whether gross margin is truly positive without one-offs.
Ownership is crowded and stable at the top, with the top 3 institutions controlling 63.6% and insiders holding 16.0%, so the shareholder base is not starved for sponsorship. Short interest at 5.85% of shares, or 68.8M shares with 2.8 days-to-cover, is elevated enough to fuel rallies on a good print but not high enough to force a structural squeeze. Near-dated options positioning is unhelpful, with negative gamma and a zero-gamma level of $41.01, slightly above spot, which can amplify downside volatility around earnings.
Management expects both to remain negative in FY27, with improvement only in the back half.
Grew mid-single digits in Q4 across Running, Training, and Global Football, the clearest current area of underlying health.
Revenue grew 10% in Q4, helped by improved partner trends and the first positive Foot Locker read in 4 years.
Revenue fell 17% in Q4, and management expects near-term performance to stay in line with recent trends.
Guidance turned more cautious as Nike now sees revenue down low to mid-single digits into Q1/Q2.
Execution has improved from a very weak 2025 Q1 setup, but credibility is still mixed. Back then management withdrew FY25 guidance, guided Q2 revenue down 8% to 10% and gross margin down about 150 bps, and said, "we have yet to turn the corner." Since then, the company has delivered a strong beat streak, including 8 straight EPS beats, and materially improved margins, with FY2026 operating margin at 10.4% versus 8.0% in the prior year and Q4 EBITDA margin at 12.9%. But the strategic reset has not restored growth: FY2026 revenue still fell 6.9%, China was down 17% in Q4, and current guidance still calls for low to mid-single digit revenue declines. The promised portfolio reset did happen, with classic franchises reduced by more than $2B in FY26, yet the outcome so far is cleaner inventory and better margins, not a durable return to growth. Management looks credible on cost actions and channel repair, less credible on timing the demand recovery.
Specifically for the first quarter, we expect reported revenues to be down low to mid-single digits with no expected benefit from foreign exchange and currency-neutral revenue growth consistent with recent performance. We expect gross margin in Q1 to be slightly positive.
We are not expecting the environment to improve meaningfully over the next 6 months.
Our fourth quarter financial performance was in line with our expectations. However, the operating environment became more challenging as we progressed through the quarter.
We expect Sportswear and Jordan Streetwear to continue to be negative this fiscal year with improvement expected in the back half. Together, they represent approximately half of our revenue.
This resulted in the recognition of a one-time benefit of $986 million, offsetting the IEEPA tariffs embedded within cost of sales that had been expensed throughout fiscal '26.
Nike's moat is still built on global brand equity, athlete marketing, and unmatched wholesale and direct distribution. That moat remains durable enough to keep the company relevant, but it is less dominant because product misses in lifestyle allowed newer brands to gain traction and because channel power no longer guarantees demand. The moat is strongest in performance categories, where Q4 growth was mid-single digits, and weakest in lifestyle, where Sportswear and Jordan Streetwear, about half of revenue, are still negative.
Capital allocation is defensive, not aggressive. FY2026 free cash flow was only $1.5B, capex was just $0.1B, buybacks were $0.0B, and dividends consumed $0.6B, which suggests management is preserving flexibility rather than pressing shareholder returns. That is disciplined in a reset, but it also tells investors the cash engine is not yet back to old Nike levels.
NKE rates SELL at Medium conviction. The brand is intact and margins are improving, but the near-term earnings power is weaker than the headline quarter suggests and the revenue base is still under pressure in too many important places. A stock down almost 49% from the high can still be expensive if the recovery is slow, and this one still looks slow. A move to neutral would require evidence that 2H FY27 product launches are driving sustained growth in Sportswear and Jordan, and that China is stabilizing beyond the current 17% decline pattern.
≣ Full research note tap to expand
Executive Summary
SELL, Medium conviction. Rated SELL, Medium conviction. The issue is not brand survival, it is earnings power: FY2026 revenue fell to $46.4B, EPS fell to $2.10, and the latest quarter's headline EPS was flattered by a $986M one-time tariff recovery, while management still says, "We are not expecting the environment to improve meaningfully over the next 6 months." The stock is down 48.8% from the 52-week high, but the forward setup still looks like a slow reset rather than a clean inflection.
Investment Thesis
Nike is no longer the broken story it was a year ago, but it is not yet the recovered story the valuation still implies. The hard evidence is straightforward: FY2026 revenue fell to $46.4B, down 6.9%, EPS dropped 19.7% to $2.10, and the latest quarter's reported $0.72 EPS was flattered by a $986M one-time tariff recovery. Ex-benefit EPS was only $0.20. That makes the apparent earnings momentum look much better than the underlying business actually is.
The central debate is whether the margin recovery can carry the stock before demand returns. There is progress here. FY2026 operating margin improved to 10.4% from 8.0%, Q4 EBITDA margin reached 12.9%, the company took more than $2B out of classic footwear franchises to clean up the portfolio, and North America wholesale grew 10%. Those are real wins. But they sit beside management's own warning that "We are not expecting the environment to improve meaningfully over the next 6 months." Even more important, Elliott Hill said Sportswear and Jordan Streetwear will remain negative this fiscal year, and together they are approximately half of revenue. That is not a minor pocket of weakness. It is the core of the revenue base.
The market also has to deal with an uneven moat. Nike still owns one of the few truly global athletic brands, and that matters. But the competitive advantage has shifted away from broad lifestyle dominance toward narrower strength in performance categories. Q4 performance sports grew mid-single digits, while China fell 17% and lifestyle remains under pressure. That leaves the company with a durable franchise, but a less powerful growth engine than investors were accustomed to three to five years ago.
At this price, the risk is not permanent impairment, it is dead money or another leg down if the next few quarters confirm that growth is still missing. The stock is already down 48.8% from the 52-week high and 23.9% below the 200-day average, so the easy bearish money has likely been made. That keeps conviction at Medium, not High. But absent a cleaner proof that new product launches in 2H FY27 can offset weakness in half the portfolio and stabilize China, the setup still favors a SELL over patience.
Key Metrics
| Metric | Value | Context |
|---|---|---|
| Current price | $39.60 | Engine base target implies only 0.2% upside |
| Price target | $39.67 | Ground-truth target, Medium confidence, basis earnings_growth_blend |
| FY2026 revenue | $46.4B | -6.9% YoY, still shrinking despite reset actions |
| FY2026 EPS | $2.10 | -19.7% YoY, weak earnings base for a turnaround |
| Operating margin | 10.4% | Up from 8.0% in prior FY, clear cost and mix recovery |
| Valuation | P/E 18.26x, P/S 1.23x | P/E roughly in line with peer avg 18.1x, P/S below peer avg 1.5x |
| Leverage | Debt/EBITDA 2.79x | Manageable, but not balance-sheet-clean for a consumer reset story |
| Free cash flow | $1.5B | Low versus historic Nike standards, with capex only $0.1B |
| Q4 FY26 EBITDA | $1.42B | 12.9% margin, up 690 bps vs Q1 FY26 |
| Q1 FY27 guidance | Revenue down low to mid-single digits | Gross margin only slightly positive, SG&A dollars flat |
| 52-week position | -48.8% vs high | Stock near lows, now $38.17-$77.37 52-week range |
| Short interest | 5.85% | 68.8M shares short, 2.8 days-to-cover |
Financial Strength
Nike's balance sheet is still serviceable, not pristine. A 1.96 current ratio and 0.74 debt-to-equity support near-term flexibility, and leverage at 2.79x debt/EBITDA is manageable for a global brand with positive free cash flow. The concern is that free cash flow at $1.5B is modest relative to the size of the franchise and sits alongside very low capex and no buybacks, which signals a business still protecting liquidity rather than leaning into offense. Margin trajectory is the better part of the financial story, but cash generation has not yet caught up.
Competitive Position
Nike's moat is still built on global brand equity, athlete marketing, and unmatched wholesale and direct distribution. That moat remains durable enough to keep the company relevant, but it is less dominant because product misses in lifestyle allowed newer brands to gain traction and because channel power no longer guarantees demand. The moat is strongest in performance categories, where Q4 growth was mid-single digits, and weakest in lifestyle, where Sportswear and Jordan Streetwear, about half of revenue, are still negative.
Management & Guidance
Management's latest guide is cautious and should be taken at face value. The CFO said, "Specifically for the first quarter, we expect reported revenues to be down low to mid-single digits... We expect gross margin in Q1 to be slightly positive." He also said, "We are not expecting the environment to improve meaningfully over the next 6 months." That aligns with the broader message from the call: operating conditions worsened through the quarter, China remains weak, and Sportswear plus Jordan Streetwear, approximately half of revenue, will stay negative this fiscal year. The beat history gives management some credit on quarterly cost control, but the one-time $986M tariff recovery means investors should trust the revenue caution more than the headline EPS strength.
Segment Analysis
- Sportswear and Jordan Streetwear (approximately 50% of revenue): Management expects both to remain negative in FY27, with improvement only in the back half.
- Performance sports (not disclosed): Grew mid-single digits in Q4 across Running, Training, and Global Football, the clearest current area of underlying health.
- North America wholesale (not disclosed): Revenue grew 10% in Q4, helped by improved partner trends and the first positive Foot Locker read in 4 years.
- Greater China (not disclosed): Revenue fell 17% in Q4, and management expects near-term performance to stay in line with recent trends.
Capital Allocation
Capital allocation is defensive, not aggressive. FY2026 free cash flow was only $1.5B, capex was just $0.1B, buybacks were $0.0B, and dividends consumed $0.6B, which suggests management is preserving flexibility rather than pressing shareholder returns. That is disciplined in a reset, but it also tells investors the cash engine is not yet back to old Nike levels.
Management Execution & Track Record
Execution has improved from a very weak 2025 Q1 setup, but credibility is still mixed. Back then management withdrew FY25 guidance, guided Q2 revenue down 8% to 10% and gross margin down about 150 bps, and said, "we have yet to turn the corner." Since then, the company has delivered a strong beat streak, including 8 straight EPS beats, and materially improved margins, with FY2026 operating margin at 10.4% versus 8.0% in the prior year and Q4 EBITDA margin at 12.9%. But the strategic reset has not restored growth: FY2026 revenue still fell 6.9%, China was down 17% in Q4, and current guidance still calls for low to mid-single digit revenue declines. The promised portfolio reset did happen, with classic franchises reduced by more than $2B in FY26, yet the outcome so far is cleaner inventory and better margins, not a durable return to growth. Management looks credible on cost actions and channel repair, less credible on timing the demand recovery.
Positioning & Flows
Ownership is crowded and stable at the top, with the top 3 institutions controlling 63.6% and insiders holding 16.0%, so the shareholder base is not starved for sponsorship. Short interest at 5.85% of shares, or 68.8M shares with 2.8 days-to-cover, is elevated enough to fuel rallies on a good print but not high enough to force a structural squeeze. Near-dated options positioning is unhelpful, with negative gamma and a zero-gamma level of $41.01, slightly above spot, which can amplify downside volatility around earnings.
Bull Case
- Operating margin improved to 10.4% in FY2026 from 8.0% in the prior year, showing the supply-chain and portfolio reset is producing real cost leverage.
- Q4 EBITDA reached $1.42B at a 12.9% margin, up 690 bps versus Q1 FY26 and 770 bps versus prior-year Q4, indicating better operating discipline.
- Performance sports grew mid-single digits in Q4, and North America wholesale grew 10%, with Foot Locker turning positive for the first time in 4 years.
- Classic footwear franchises were reduced by more than $2B in FY26, which should clean the channel and support a healthier product mix into 2H FY27.
Bear Case
- Normalized profitability is weaker than the headline quarter suggests, because the $0.72 Q4 EPS falls to $0.20 excluding the $986M tariff benefit.
- Greater China revenue fell 17% in Q4, and management said near-term trends should remain in line with recent performance, leaving a major geography without a visible rebound.
- Management explicitly said, "We are not expecting the environment to improve meaningfully over the next 6 months," while guiding only slightly positive Q1 gross margin and flat SG&A dollars.
- Valuation is not washed out enough for a shrinking earnings base: NKE trades at 18.26x earnings, essentially in line with the 18.1x peer average, despite lower growth and wide peer dispersion of 3.4x.
Valuation & Price Target
Engine price target $39.67 (+0.2% vs current), Medium confidence.
- P/E Multiple: $30.79 (28% weight)
- P/S Multiple: $51.24 (20% weight)
- Quality-adjusted: $35.48 (20% weight)
- DCF: $51.49 (9% weight)
The quant baseline is HOLD with a $39.67 target, just 0.2% above the current $39.60, and that math is internally consistent. The divergence to SELL comes from trajectory, not arithmetic. The engine target blends methods ranging from $30.79 on P/E to $51.49 on DCF, but the peer set carries wide dispersion of 3.4x, and NKE's own fundamentals argue against leaning on richer sales-based methods while revenue is still falling and normalized Q4 EPS was only $0.20 ex-tariff benefit. At 18.26x earnings versus peers at 18.1x, investors are not getting a clear discount for a business with FY2026 revenue down 6.9%, EPS down 19.7%, and management guiding another soft six months. Sell-side consensus still tilts Buy, 7 buy / 13 hold / 2 sell, but that is low-signal context and does not offset the weaker forward earnings setup.
Risk Assessment
Risk score 53/100 (Moderate). The biggest risk to the bearish view is that margin repair outruns revenue pressure, because FY2026 operating margin already recovered to 10.4% from 8.0% and Q4 EBITDA margin hit 12.9%.
The Bottom Line
NKE rates SELL at Medium conviction. The brand is intact and margins are improving, but the near-term earnings power is weaker than the headline quarter suggests and the revenue base is still under pressure in too many important places. A stock down almost 49% from the high can still be expensive if the recovery is slow, and this one still looks slow. A move to neutral would require evidence that 2H FY27 product launches are driving sustained growth in Sportswear and Jordan, and that China is stabilizing beyond the current 17% decline pattern.
Go deeper in the app
Live charts, options analytics, the full earnings-call breakdown, price alerts, and every other stock — updated in real time.
Get Tickr